A centuries-old herbal medicine, discovered by Chinese scientists and used to effectively treat malaria, has been found to potentially aid in the treatment of tuberculosis and may slow the evolution of drug resistance.
In a promising study led by Robert Abramovitch, a Michigan State University microbiologist and TB expert, the ancient remedy artemisinin stopped the ability of TB-causing bacteria, known as Mycobacterium tuberculosis, to become dormant. This stage of the disease often makes the use of antibiotics ineffective.
The study is published in the journal Nature Chemical Biology.
“When TB bacteria are dormant, they become highly tolerant to antibiotics,” Abramovitch said, an assistant professor in the College of Veterinary Medicine. “Blocking dormancy makes the TB bacteria more sensitive to these drugs and could shorten treatment times.”
One-third of the world’s population is infected with TB and the disease killed 1.8 million people in 2015, according to the Centers for Disease Control and Prevention.
Mycobacterium tuberculosis, or Mtb, needs oxygen to thrive in the body. The immune system starves this bacterium of oxygen to control the infection. Abramovitch and his team found that artemisinin attacks a molecule called heme, which is found in the Mtb oxygen sensor. By disrupting this sensor and essentially turning it off, the artemisinin stopped the disease’s ability to sense how much oxygen it was getting.
“When the Mtb is starved of oxygen, it goes into a dormant state, which protects it from the stress of low-oxygen environments,” Abramovitch said. “If Mtb can’t sense low oxygen, then it can’t become dormant and will die.”
Abramovitch indicated that dormant TB can remain inactive for decades in the body. But if the immune system weakens at some point, it can wake back up and spread. Whether it wakes up or stays ‘asleep’ though, he said TB can take up to six months to treat and is one of the main reasons the disease is so difficult to control.
“Patients often don’t stick to the treatment regimen because of the length of time it takes to cure the disease,” he said. “Incomplete therapy plays an important role in the evolution and spread of multi-drug resistant TB strains.”
He said the research could be key to shortening the course of therapy because it can clear out the dormant, hard-to-kill bacteria. This could lead to improving patient outcomes and slowing the evolution of drug-resistant TB.
After screening 540,000 different compounds, Abramovitch also found five other possible chemical inhibitors that target the Mtb oxygen sensor in various ways and could be effective in treatment as well.
“Two billion people worldwide are infected with Mtb,” Abramovitch said. “TB is a global problem that requires new tools to slow its spread and overcome drug resistance. This new method of targeting dormant bacteria is exciting because it shows us a new way to kill it. ”
Learn more: ANCIENT CHINESE MALARIA REMEDY FIGHTS TB
Receive an email update when we add a new TUBERCULOSIS article.
The Latest on: Tuberculosis
via Google News
The Latest on: Tuberculosis
- N. Korea to receive $42 mln to fight tuberculosis, malaria: reporton January 23, 2020 at 10:38 pm
The Global Fund, an organization set up to fight epidemic diseases, will provide $42 million to help North Korea fight tuberculosis and malaria, according to the Voice of America on Friday. In an ...
- Health care worker could have exposed hundreds in Oakland, Macomb to tuberculosison January 23, 2020 at 7:41 pm
A health care worker may have exposed patients to TB in Ascension Medical Group Michigan locations in Macomb Township, Rochester and St. Clair Shores.
- Q&A with health department after tuberculosis reported at Metro Detroit clinicon January 23, 2020 at 6:04 pm
MACOMB COUNTY, Mich. – The Michigan Department of Health and Human Services answered questions regarding tuberculosis after patients were potentially exposed to the illness over a nine month period at ...
- Source: Baby with tuberculosis was patient at Macomb County clinic where employee who had illness workedon January 23, 2020 at 4:41 pm
MACOMB COUNTY, Mich. – A source close to a family whose newborn has tuberculosis said the infant was a patient at a Macomb Township clinic where a worker was diagnosed with the illness. The source ...
- Tuberculosis exposure investigated at metro Detroit physician practice locationson January 23, 2020 at 2:08 pm
Patients at the Ascension Medical Group locations in Macomb Township, Rochester and St. Clair Shores were in close contact with a healthcare associate recently diagnosed with tubercolosis.
- Southeast Michigan Physician Practice Locations Being Investigated For Tuberculosis Exposureon January 23, 2020 at 9:29 am
Rochester and St. Clair Shores to determine the health status of patients identified as being in close contact with a healthcare associate recently diagnosed with pulmonary tuberculosis. The ...
- Tuberculosis Exposure Investigated In Metro Detroiton January 23, 2020 at 8:27 am
State health officials are working to investigate TB exposure in Rochester, St. Clair Shores and Macomb Township.
- BCG revaccination shows potential to boost immunity against tuberculosison January 23, 2020 at 6:58 am
When young Indian adults, who have been vaccinated at birth, are once again given the BCG vaccine, their immune response against tuberculosis (TB) improves and they may be less likely to develop the ...
- Anti-tuberculosis Therapeutics Market By Current Industry Status,Growth Opportunities, Top Key Players, Target Audience And Forecast To 2025on January 23, 2020 at 1:26 am
A recent report provides crucial insights along with application based and forecast information in the Global Anti-tuberculosis Therapeutics Market. The report provides a comprehensive analysis of key ...
via Bing News